Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma

Abstract

Introduction: Since currently no sensitive and specific biomarkers for early detection of lung adenocarcinoma (AD) exist and the majority of AD patients are diagnosed at late stages of disease, the development of effective screening tests for early-stage lung AD is urgently needed. Serum microRNAs (miRNAs) have been documented as novel noninvasive biomarkers in tumor diagnosis; thus, we studied the profile of serum miRNA in AD patients in order to identify the differentially expressed miRNAs as potential biomarkers for early detection of AD.Patients and Methods: Serum samples were collected from 180 AD patients and 180 age- and sex-matched healthy controls. Serum miRNA profiling was performed by low-density array (LDA) using RNA extracted from blood samples of 20 patients and 20 controls. To validate the selected miRNAs, a stem-loop based RT-qPCR assay was used and serum samples from 160 patients and 160 controls were examined.Results: Profiling data showed 11 differentially expressed miRNAs in the serum samples from AD patients compared with the controls. Among them, 6 selected miRNAs in AD patients, including miR-103, miR-146a, miR-151, miR-21, miR-221, miR-222, and miR-223, were validated by RT-qPCR. In particular, the top three, miR-146a, miR-222, and miR-223, were confirmed to be significantly expressed in stage I/II AD patients compared with healthy controls.Conclusion: A panel of miRNAs with miR-146a, miR-222 and miR-223 could be used as potential noninvasive biomarkers for early detection of AD.

miR‐146a‐5p: Expression, regulation, and functions in cancer

“…Contradicting these findings, Wang et al saw higher miR‐146a levels in NSCLC patient serum compared to healthy controls (Wang, Zheng, Wang, & Zhang, ). Lv et al () published similar results 2 years later, and they saw a specific increase in serum miR‐146a concentrations in stage I and II lung adenocarcinoma patients. These studies show that miR‐146a can be confidently detected in human serum.…”

Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer

“…Further, a panel of three miRNAs (miR-146a, miR-222 and miR-223) is identified as a biomarker for early detection in lung cancer [ 33 ]. The expression of colon cancer associated miRNAs in serum indicates that the tumor expresses high levels of the specific miRNA, thus these results published by others support our finding of these miRNAs as prognostic biomarkers in colon cancer.…”

hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma

“…NSCLC is further histologically subdivided into four categories: (a) lung adenocarcinoma (LAC); (b) squamous cell carcinoma; (c) large cell carcinoma; and (d) others. Of those, LAC is the most common type, and is responsible for more than 500 000 deaths in the world each year because it is often diagnosed at an advanced stage .Thus, an early diagnosis appears to be a promising measure for improving the prognoses of patients with LAC . Therefore, the identification of ideal molecular diagnostic markers for early detection of LAC is urgently needed.…”